Abattis Bioceuticals Corp. (ATTBF)

Abattis Bioceuticals Revenue

In the fiscal year ending September 30, 2019, Abattis Bioceuticals had annual revenue of 356.88K CAD with 4,163.24% growth. Abattis Bioceuticals had revenue of 226.27K in the quarter ending September 30, 2019, with 9,064.32% growth.

• Revenue: 356.88K CAD
• Revenue Growth: +4,163.24%
• P/S Ratio: 0.00
• Revenue / Employee: n/a
• Employees: n/a
• Market Cap: 476.00 USD

Revenue Chart

* This company reports financials in CAD.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Sep 30, 2019	356.88K	348.51K	4,163.24%
Sep 30, 2018	8.37K	-	-
Sep 30, 2017	-	-	-
Sep 30, 2016	-	-	-
Sep 30, 2015	91.94K	84.22K	1,090.93%